ARCHIVES

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011

NCI Suggests 75 Topics for SBIR Proposals

October 4, 1985

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013